A staggering number of clinical trials fail to meet recruitment goals, leading to delays, early termination, or inability to draw conclusions at trial completion due to loss of statistical power. It is estimated that roughly 80% of clinical trials fail to meet enrolment timelines and approximately 30% of Phase III study terminations are due to enrolment difficulties. Joanne Yeoh and Aina Farhana at Clinical Research Malaysia demonstrates how the impact of failure to enrol patients and meet with timelines can delay product launch that could translate into huge financial losses.